ThermoLife International LLC v. Neogenis Labs Incorporated

District Court, D. Arizona·Decided July 1, 2021·No. 2:18-cv-02980·Unknown

Opinion

1 WO 2 3 4 5

9 ThermoLife International LLC, No. CV-18-02980-PHX-DWL

10 Plaintiff, ORDER

11 v.

12 Neogenis Labs Incorporated,

13 Defendant. 14 NeoGenis Labs Incorporated,

15 Counter-Claimant,

16 v.

17 ThermoLife International LLC and Ronald L. Kramer, 18 Counter-Defendants. 19

21 Pending before the Court is ThermoLife’s renewed motion to voluntarily dismiss 22 the Second Amended Complaint (“SAC”) without prejudice. (Doc. 202.) For the 23 following reasons, the motion is granted. 25 As discussed in earlier orders (Doc. 201), this action has been pending for almost 26 three years. The Court and the parties have plodded through (1) two motions to dismiss 27 ThermoLife’s complaint (Docs. 40, 63 [orders resolving motions]), resulting in the 28 operative SAC; (2) two motions to dismiss HumanN’s counterclaims (Docs. 113, 176 1 [orders resolving motions]); (3) several requests to stay the case pending settlement 2 discussions (Docs. 76, 78, 80, 82); (4) several requests to extend case deadlines (Docs. 116, 3 124, 184); and (5) various discovery disputes (Docs. 128, 130, 139, 142, 147, 175, 177). 4 Fact discovery is set to close on July 23, 2021. (Doc. 208.) Even more discovery disputes 5 have popped up in the last few days. (Docs. 219, 222.) 6 Meanwhile, on February 11, 2021, ThermoLife filed separate lawsuit against 7 HumanN in the Western District of Texas (the “Texas Litigation”), alleging that three of 8 HumanN’s products—SuperBeets, BeetElite, and Neo40—infringe three of its patents: 9 Patent Nos. 9,180,140 (the “’140 Patent”), 8,455,531 (the “’531 Patent”), and 10,555,968 10 (the “’968 Patent”). (Doc. 174-1.) On April 7, 2021, HumanN filed an answer and asserted 11 counterclaims against ThermoLife in the Texas Litigation. (Doc. 174-2.) HumanN’s three 12 products, and ThermoLife’s past assertions of infringement related to the ’140 and ’531 13 Patents, are also at issue in this lawsuit. 14 Recently, ThermoLife requested a stay of HumanN’s counterclaims in this action, 15 arguing (among other things) that the Texas Litigation would “resolve legal disputes 16 between the parties that [would] be dispositive to likely all of HumanN’s counterclaims.” 17 (Doc. 189 at 4, 6-8.) HumanN disagreed, arguing that it would be prejudiced by a stay and 18 questioning whether the issues in the Texas Litigation would be dispositive of the issues in 19 this action. (Doc. 199.) In this briefing, the parties also disputed whether, assuming a stay 20 was granted, voluntary dismissal of ThermoLife’s claims would be proper. (Doc. 189 at 21 8-10; Doc. 199 at 13-17; Doc. 200 at 9-11.) 22 The Court denied ThermoLife’s stay request, explaining (among other things) that 23 “even if a ruling in the Texas Litigation might simplify the issues in this case, ThermoLife 24 [had] not shown that such potential for simplification would justify an indefinite stay of 25 this action, which has been pending for almost three years and is on the cusp of the close 26 of discovery, when the alternative is forcing this Court to await a ruling in a suit filed only 27 a few months ago on issues it is fully capable of resolving itself in due course.” (Doc. 201 28 at 7.) And “because ThermoLife conditioned the voluntary dismissal of its claims on the 1 granting of a stay, the dismissal request [was] denied as moot.” (Id. at 8.) 2 Soon afterward, ThermoLife filed the pending motion. (Doc. 202.) ThermoLife 3 seeks to dismiss its claims without prejudice under Rule 41(a), with two conditions: “(1) 4 that ThermoLife not refile the claims set forth in the Second Amended Complaint unless 5 and until the Texas Patent Litigation finally resolves, including all appeals; and (2) if 6 ThermoLife refiles the claims set forth in the Second Amended Complaint, it must refile 7 them in this jurisdiction (absent an agreement by HumanN otherwise).” (Id. at 1.) 8 On June 11, 2021, HumanN filed a response. (Doc. 209.) 9 On June 23, 2021, ThermoLife filed a reply. (Doc. 218.)1 Neither side requested 10 oral argument. 12 I. Legal Standard 13 Rule 41(a)(2) of the Federal Rules of Civil Procedure provides: 14 Except as provided in Rule 41(a)(1), an action may be dismissed at the plaintiff’s request only by court order, on terms that the court considers 15 proper. If a defendant has pleaded a counterclaim before being served with 16 the plaintiff’s motion to dismiss, the action may be dismissed over the defendant’s objection only if the counterclaim can remain pending for 17 independent adjudication. Unless the order states otherwise, a dismissal 18 under [Rule 41(a)(2)] is without prejudice. 19 Whether to grant a motion for voluntary dismissal under Rule 41(a)(2) is a matter of “the 20 district court’s sound discretion.” Stevedoring Servs. of Am. v. Armilla Int’l B.V., 889 F.2d 21 919, 921 (9th Cir. 1989). “In exercising its discretion, the Court must make three separate 22 determinations: (1) whether to allow the dismissal at all; (2) whether the dismissal should 23 be with or without prejudice; and (3) what terms and conditions, if any, should be 24 imposed.” Burnette v. Godshall, 828 F. Supp. 1439, 1443 (N.D. Cal. 1993). 25 …

26 1 The operative reply is ThermoLife’s amended reply. ThermoLife sought to file its initial reply under seal but the Court denied the sealing request without prejudice because 27 ThermoLife gave “no reasons whatsoever to justify sealing, other than the assertion that the documents at issue were designated as confidential.” (Doc. 216 at 2.) On June 23, 28 2021, ThermoLife filed its amended reply (Doc. 218) and a notice that ThermoLife “determined that [it] could file a modified version of the Reply publicly.” (Doc. 217.) 1 II. The Parties’ Arguments 2 ThermoLife argues that dismissal is proper because HumanN would not lose any 3 “substantial right” by dismissal and would “instead benefit . . . by avoiding the expense of 4 litigating claims against it.” (Doc. 189 at 8.) ThermoLife also argues that HumanN will 5 benefit from its proposed conditions of dismissal—i.e., “(1) that ThermoLife not refile the 6 claims set forth in the Second Amended Complaint unless and until the [Texas Litigation] 7 finally resolves, including all appeals; and (2) if ThermoLife refiles the claims set forth in 8 the Second Amended Complaint, it must file them in this jurisdiction (absent an agreement 9 by HumanN otherwise).” (Doc. 202 at 1.) Last, ThermoLife argues that any dismissal 10 should be without prejudice because the case is still in the discovery stage, HumanN has 11 “not had to prepare for trial,” and the parties will likely reach a “final resolution” of their 12 disputes in the Texas Litigation. (Doc. 189 at 9.) 13 HumanN opposes ThermoLife’s request, arguing that dismissal would be improper 14 because ThermoLife “waited two-and-a-half years before bringing its serial motions to 15 voluntarily dismiss, and in both iterations, it has given no explanation for why it delayed 16 so long in requesting voluntary dismissal.” (Doc. 209 at 5, internal quotation marks 17 omitted). HumanN also argues that it will face “obvious prejudice were ThermoLife 18 allowed to walk away from this case now, right before the close of discovery, only to re- 19 file it down the road.” (Id.) Next, HumanN argues that any dismissal of ThermoLife’s 20 claims should be with prejudice because “HumanN has expended significant resources in 21 defending itself,” “ThermoLife’s lack of diligence over the last thirty-four months is 22 patent,” and ThermoLife has “offered no coherent explanation as to why it now seeks 23 dismissal of its own claims.” (Id. at 5-9.) In HumanN’s view, ThermoLife is seeking to 24 dismiss its claims now because ThermoLife knows its claims will not survive summary 25 judgment.

Free access — add to your briefcase to read the full text and ask questions with AI

ThermoLife International LLC v. Neogenis Labs Incorporated, (D. Ariz. 2021).

ThermoLife International LLC v. Neogenis Labs Incorporated (ThermoLife International LLC v. Neogenis Labs Incorporated) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related